SCHEMBL6235201

SCHEMBL6235201

COc1ccc(S(=O)(=O)N(C(C)C)C2CCCCC2)cc1N1CCNCC1

nearest known ligand 0.52

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 20/20 0.52
HTR7 P34969 1/20 0.48
HTR4 Q13639 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8084533 0.90 HTR6 (0.51) HTR6
SCHEMBL6236246 0.88 HTR6 (0.53) HTR6HTR7HTR4
SCHEMBL6234522 0.87 HTR6 (0.52) HTR6HTR7HTR4
SCHEMBL6234497 0.84 TSHR (0.65) HTR6
SCHEMBL6236033 0.84 HTR6 (0.52) HTR6
SCHEMBL32672558 0.80 HTR6 (0.58) HTR6HTR7HTR4
SCHEMBL32672532 0.79 HTR6 (0.59) HTR6HTR7HTR4
SCHEMBL6234987 0.78 HTR6 (0.58) HTR6HTR7HTR4
SCHEMBL6234992 0.78 HTR6 (0.58) HTR6HTR7HTR4
SCHEMBL6238497 0.78 HTR6 (0.58) HTR6HTR7HTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049679-B1 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 2005-06-01 EP claimed
US-6548504-B1 Compounds SMITHKLINE BEECHAM P.L.C. (GB) 2003-04-15 US claimed
EP-1049679-B1 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 2005-06-01 EP disclosed
US-6548504-B1 Compounds SMITHKLINE BEECHAM P.L.C. (GB) 2003-04-15 US disclosed
EP-1049679-A2 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 2000-11-08 EP disclosed
WO-1999037623-A2 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1999-07-29 WO disclosed